Concomitant chemo-radiotherapy as standard therapy in limited-stage small-cell oesophageal cancer : A summary of 3 clinical cases and review of the literature
Journal | Volume 71 - 2008 |
Issue | Fasc.3 - Case reports |
Author(s) | Bertrand Vos, Julien Gallez, Sébastien Debroux, Sandrine Roland, Alain Verhest, Paul Van Houtte, Ahmad Awada, Alain Hendlisz |
Full article |
VIEW FREE PDF |
(1) Gastroenterology department, (2) Pathology department, (3) Radiotherapy department, Jules Bordet Institute, Brussels, Belgium. |
Small-cell carcinoma of the oesophagus (SCCO) is a rare and aggressive malignant tumour associated with a poor prognosis. Between 1994 and 2002, three patients with SCCO were treated in our institution, representing 1.96% (3 out of 153) of all oesophageal malignancies seen during this period. All of these patients had limited-stage SCCO at initial diagnosis and were treated by chemotherapy (cisplatin and etoposide) with concomitant radio- therapy. An initial complete response of the primary lesion was observed in all cases and a persistent complete remission in two of the cases. Chemo-radiotherapy should be considered as a valuable treatment alternative to surgery for limited-stage small-cell carcinoma of the oesophagus. (Acta gastroenterol. belg., 2008, 71, 325-329). |
© Acta Gastro-Enterologica Belgica. PMID 19198580 |